Review: taking Coenzyme q10 and Pradaxa together


Summary

Drug interactions are reported among people who take Coenzyme q10 and Pradaxa together. This review analyzes the effectiveness and drug interactions between Coenzyme q10 and Pradaxa. It is created by eHealthMe based on reports of 173 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Coenzyme q10 and Pradaxa >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Coenzyme Q10

Coenzyme q10 has active ingredients of coenzyme q - 10. It is often used in supplementation therapy. (latest outcomes from Coenzyme q10 1,797 users)

Pradaxa

Pradaxa has active ingredients of dabigatran etexilate mesylate. It is often used in atrial fibrillation/flutter. (latest outcomes from Pradaxa 38,203 users)

On Aug, 26, 2016

173 people who take Coenzyme Q10, Pradaxa are studied.


Number of reports submitted per year:

Coenzyme q10 and Pradaxa drug interactions.

Drug effectiveness over time:

Coenzyme Q10:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 50.0% - (1 of 2 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Pradaxa:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 66.0% - (2 of 3 people)
  • 1 - 2 years: 100.0% - (3 of 3 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Coenzyme Q10:
  • female: 100.0% - (1 of 1 people)
  • male: 0.0% - (0 of 5 people)
Pradaxa:
  • female: 100.0% - (1 of 1 people)
  • male: 71.0% - (5 of 7 people)

Drug effectiveness by age:

Coenzyme Q10:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 16.0% - (1 of 6 people)
Pradaxa:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 75.0% - (6 of 8 people)

Most common drug interactions over time *:

< 1 month:
  • gastrointestinal haemorrhage
  • haemorrhage
  • abdominal discomfort
  • arthralgia
  • asthenia
  • blood urine present
  • dyspepsia
  • facial bones fracture
  • fall
  • gastrooesophageal reflux disease
1 - 6 months:
  • gastrointestinal haemorrhage
  • epistaxis
  • anaemia
  • dyspepsia
  • ocular hyperaemia
  • asthenia
  • dizziness
  • haematemesis
  • melaena
  • upper gastrointestinal haemorrhage
6 - 12 months:
  • gastrointestinal haemorrhage
  • haemorrhagic anaemia
  • diarrhoea
  • abdominal discomfort
  • abnormal faeces
  • acquired afibrinogenaemia
  • aphagia
  • arthralgia
  • constipation
  • contusion
1 - 2 years:
  • lipids
  • urine - bloody
  • arthritis
  • contusion
  • gastrointestinal haemorrhage
  • haemorrhagic anaemia
  • oedema peripheral
  • pain in extremity
  • rectal haemorrhage
2 - 5 years:
  • acquired afibrinogenaemia
  • neuropathy
5 - 10 years:
  • abdominal discomfort
  • aphagia
  • erectile dysfunction
  • gastrointestinal haemorrhage
  • gastrooesophageal reflux disease
  • haemoglobin decreased
  • haemorrhagic anaemia
  • oropharyngeal pain
not specified:
  • abdominal discomfort
  • epistaxis
  • dyspepsia
  • gastrointestinal haemorrhage
  • fatigue
  • nausea
  • chest discomfort
  • contusion
  • dizziness
  • fall

Most common drug interactions by gender *:

female:
  • fatigue
  • abdominal discomfort
  • fall
  • nausea
  • dyspepsia
  • dizziness
  • gastrointestinal haemorrhage
  • anaemia
  • chest discomfort
  • epistaxis
male:
  • gastrointestinal haemorrhage
  • epistaxis
  • dyspepsia
  • contusion
  • abdominal discomfort
  • arthralgia
  • atrial fibrillation
  • cough
  • pain in extremity
  • haemorrhagic anaemia

Most common drug interactions by age *:

30-39:
  • pulmonary embolism
  • pulmonary infarction
40-49:
  • atrial fibrillation
  • cardiac disorder
  • dyskinesia
  • dyspnoea
  • colitis ulcerative
  • flushing
  • paraesthesia
  • tendonitis
50-59:
  • abdominal discomfort
  • atrial fibrillation
  • blood pressure abnormal
  • epistaxis
  • faeces hard
  • gastrointestinal haemorrhage
  • haemorrhagic anaemia
  • haemorrhoids
  • joint swelling
  • musculoskeletal pain
60+:
  • epistaxis
  • gastrointestinal haemorrhage
  • dyspepsia
  • nausea
  • abdominal discomfort
  • fatigue
  • chest discomfort
  • asthenia
  • contusion
  • dizziness

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Coenzyme q10 and Pradaxa?

Can you answer these questions?

More questions for: Coenzyme q10, Pradaxa

You may be interested in these reviews

More reviews for: Coenzyme q10, Pradaxa

On eHealthMe, Coenzyme q10 (coenzyme q - 10) is often used to treat supplementation therapy. Pradaxa (dabigatran etexilate mesylate) is often used to treat atrial fibrillation/flutter. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.